Avicanna Announces Closing of Acquisition and Launch of MyMedi.ca
August 01, 2023 07:30 ET
|
Avicanna Inc.
Completed the acquisition of the Medical Cannabis by Shopper’s Drug Mart business. Launch of Avicanna’s new medical cannabis care platform MyMedi.ca. TORONTO, Aug. 01, 2023 (GLOBE NEWSWIRE) --...
Avicanna is Pleased to Announce the Initial Network of Brands on the MyMedi.ca Platform
July 28, 2023 07:30 ET
|
Avicanna Inc.
The MyMedi.ca medical cannabis care platform is preparing to launch August 1, 2023 The new cannabis care platform will offer a diverse portfolio of products, including 35 brands and over 200 SKUs...
Avicanna Subsidiary SMGH Exports Aureus Branded CBD and CBG Into Paraguay
July 17, 2023 07:30 ET
|
Avicanna Inc.
TORONTO, July 17, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
Avicanna Provides Corporate Update and Preliminary Q2 Results
June 28, 2023 07:30 ET
|
Avicanna Inc.
TORONTO, June 28, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement for Avicanna’s Proprietary SEDDS Technology Capsules for Canadian and International markets
June 26, 2023 07:30 ET
|
Avicanna Inc.
Avicanna’s proprietary SEDDS technology capsules are designed for enhanced and rapid absorption of cannabinoids. Avicanna and Medipharm intend to commercialize various formulations of Avicanna’s...
Avicanna Sponsors New Medical Cannabis Education and Training Campaign in Canada with the Canadian Consortium for the Investigation of Cannabinoids (“CCIC”)
June 22, 2023 07:30 ET
|
Avicanna Inc.
TORONTO, June 22, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on...
Avicanna and Langara College Announce Cannabinoid-Based Translational Research Collaboration and NSERC Grant
June 13, 2023 07:30 ET
|
Avicanna Inc.
This Research Collaboration will be led by Dr. Jessica Kalra’s research team and focus on characterization of Avicanna’s proprietary products and drug pipeline formulations This Research...
Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business
May 29, 2023 07:30 ET
|
Avicanna Inc.
TORONTO, May 29, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
Avicanna Announces Results of Annual General and Special Meeting and Provides Corporate Update
May 17, 2023 17:30 ET
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Avicanna Reports Q1 2023 Financial Statement
May 16, 2023 07:30 ET
|
Avicanna Inc.
TORONTO, May 16, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing,...